A Pilot Study of Dabrafenib and Trametinib for Patients With BRAF Mutated Ameloblastoma
Phase of Trial: Phase II
Latest Information Update: 21 May 2018
At a glance
- Drugs Dabrafenib (Primary)
- Indications Benign tumours
- Focus Therapeutic Use
- 27 Jul 2017 Status changed from not yet recruiting to recruiting.
- 12 Jul 2017 Planned End Date changed from 1 Apr 2020 to 1 Aug 2020.
- 12 Jul 2017 Planned primary completion date changed from 1 Jun 2019 to 1 Oct 2019.